OncoMed Pharmaceuticals, Inc., Fluidigm Corporation to Analyze Tumor Cell Populations
1/6/2010 9:37:18 AM
More...
|
Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals, Inc.'s Lead Antibody
8/7/2009 10:53:02 AM
More...
|
OncoMed Pharmaceuticals, Inc. Appoints Sunil Patel Senior Vice President, Corporate Development
7/7/2009 9:43:06 AM
More...
|
OncoMed Pharmaceuticals, Inc. Extends License Agreement for Use of MorphoSys AG's Core Technology
6/16/2008 6:45:31 AM
More...
|
OncoMed Pharmaceuticals, Inc. Chooses SynCo Bio Partners B.V. to Fill and Finish its Lead Antibody
4/15/2008 9:13:55 AM
More...
|
GlaxoSmithKline (GSK) and OncoMed Pharmaceuticals, Inc. Confirm $1.4B Deal
1/14/2008 9:13:26 AM
More...
|
GlaxoSmithKline (GSK) Signs $1.4B Cancer Drug Deal with OncoMed Pharmaceuticals, Inc. (Jobs)
12/10/2007 6:09:06 AM
More...
|
OncoMed Pharmaceuticals, Inc. Appoints William D. Waddill Senior Vice President and Chief Financial Officer
10/30/2007 8:17:15 AM
More...
|
OncoMed Pharmaceuticals, Inc. Appoints Steven E. Benner, M.D., Senior Vice President And Chief Medical Officer
2/21/2007 10:47:27 AM
More...
|
OncoMed Pharmaceuticals, Inc. Granted Fundamental Patent For Identifying Therapeutics Targeting Cancer Stem Cells
10/17/2006 11:05:07 AM
More...
|
|